February 19 2019 - Pfizer’s forgotten cancer pill may become its next blockbuster

Pfizer’s forgotten cancer pill may become its next blockbuster
Intercept Pharma one step closer to filing for approval of first NASH treatment
Teva aims for 25% of EpiPen market by 2020
Microbiome company Kaleido Bio announces $120M IPO
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*

NEW board: Ask an Employment Attorney -- a chance to discuss employment-related legal issues with a practicing attorney with over 20 years in employment law experience. Read the latest answer -- about employment agreements under Chapter 11.

Today's most popular searches: